GENB
GENB
US3709201004
Generate Biomedicines, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 31.893.000 20.459.000
55.9%
Cost of Revenue -- --
--
Gross Profit -- --
--
266.958.000 217.398.000
22.8%
Operating Income -235.065.000 -196.939.000
19.4%
Pretax Income -222.802.000 -181.172.000
23.0%
Net Income Common Stockholders -249.523.000 -213.777.000
16.7%
-- --
--
-- --
--
ende